Skip to main navigation
Theratechnologies Inc. Theratechnologies Inc.

    About

  • About
    • About Us
    • Board of Directors
    • Leadership Team
    • Scientific Consultants & Advisors
    • Awards
  • Medicines & Pipeline

  • Medicines & Pipeline
    • Medicines
      • Trogarzo®
      • EGRIFTA SV®
      • EGRIFTA®
    • Pipeline & Science
      • Hepatology
        • Tesamorelin for the Potential Treatment of NASH
        • Scientific Papers
        • Clinical Trials
        • Patient Information
      • Oncology
        • SORT1+ Technology™
        • TH1902
        • TH1904
        • Scientific Papers
        • Clinical Trials
        • Patient Information
      • HIV
        • F8 in HIV-Associated Excess Abdominal Fat
        • Scientific Papers
        • Clinical Trials
        • Patient Information
      • Expanded Access Policy
      • Grants/ISRs/IITs
  • IR Nav

  • Investors
    • Overview
    • News, Events & Presentations
      • Press Releases
      • Company Announcements
      • Events
      • Corporate Presentations
    • Stock Information
      • Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Financial Information
      • SEC Filings
      • SEDAR Filings
      • Financial Reports
    • Corporate Governance
      • Documents & Charters
      • Board of Directors
      • Leadership Team
      • Committee Composition
    • Investor Resources
      • Contact IR
      • FAQs
  • Corporate Responsibility

  • Corporate Responsibility
  • Careers

  • Careers
  • Contact Us

  • Contact Us
  • en
    • en
    • fr
  • btn Alerts

  • Sign up for Email Alerts

Social icons

Press Releases

Investors

IR Nav

  • Overview
  • News, Events & Presentations
    • Press Releases
    • Company Announcements
    • Events
    • Corporate Presentations
  • Stock Information
    • Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Financial Information
    • SEC Filings
    • SEDAR Filings
    • Financial Reports
  • Corporate Governance
    • Documents & Charters
    • Board of Directors
    • Leadership Team
    • Committee Composition
  • Investor Resources
    • Contact IR
    • FAQs

Stock

Prices shown in CAD

Jun 24, 2022 10:13 PM EDT

btn Stock

Learn More

IR Tools

  • Email Alerts
  • Contact IR
  • RSS Feeds

Press Releases

Latest

May 31, 2022
Theratechnologies Announces New Head of Investor Relations
news
Press Releases
Jul 30, 2020
Theratechnologies To Present At The Canaccord Genuity 40th Annual Growth Conference On August 12, 2020
Jul 23, 2020
Theratechnologies Reports That Tesamorelin Improves Liver Health
Jul 16, 2020
Announcements In Conjunction With Theratechnologies Annual Meeting
Jul 15, 2020
Theratechnologies Announces Financial Results For The Second Quarter Of Fiscal 2020
Jul 07, 2020
Theratechnologies Confirms Bioequivalence Of New Tesamorelin Formulation
Jul 06, 2020
Theratechnologies Announces Ibalizumab Inhibits HIV-2 In Vitro
Jun 26, 2020
Theratechnologies To Announce Financial Results For Second Quarter 2020
Jun 22, 2020
New Data Show Theratechnologies’ SORT1+ Technology Is Effective In Many Treatment-Resistant Cancers
May 15, 2020
Theratechnologies Unveils New Positive Data For Its Investigational Peptide-Drug Conjugates Targeting Sortilin Positive Cancers
May 12, 2020
Theratechnologies To Present At The RBC Capital Markets Global Healthcare Conference On May 19, 2020
  • First page «
  • Previous page ‹
  • …
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Current page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • …
  • Next page ›
  • Last page »
Displaying 71 - 80 of 281

Headquarters

Theratechnologies inc.
2015 Peel Street, 11th Floor
Montréal, Québec
Canada H3A 1T8
Phone: 514 336-7800
Fax: 514 331-9691

European Headquarters

Theratechnologies Europe Limited
2 Hume Street, 4th floor
Dublin 2
Ireland D02 DV24
Phone: +353 1 215 0650
europe@theratech.com

Investor Relations

Elif McDonald
Senior Director, Investor Relations
Phone: +1-438-315-8563
ir@theratech.com

US Headquarters

Theratechnologies U.S., Inc.
101 Hudson Street
21st Floor
Jersey City, New Jersey 07302

Main Nav

  • Home
  • About
  • Medicines & Pipeline
  • Investors
  • Corporate Responsibility
  • Careers
  • Contact Us
©2022 - Theratechnologies Inc.

Legal Nav

  • Terms of Use
  • Privacy

Search

Theratechnologies